News

Hereditary sensory autonomic neuropathy type II: Report of two novel mutations in the FAM134B gene

Dates

on the November 18, 2019

Collaborative research project led by Prof. T. Stojkovic (APHP, GH-Pitié-Salpêtrière, Centre de référence des maladies neuromusculaires, Paris, France) to which Prof. A. Toutain participated.

Hereditary sensory autonomic neuropathy type II: Report of two novel mutations in the FAM134B gene

Abstract

Hereditary sensory autonomic neuropathy (HSAN) type II is a rare, autosomal recessive, and early onset sensory neuropathy, characterized by severe and progressive sensation impairment, leading to ulcero-mutilating complications. FAM134B gene, also known as RETREG1 gene, mutations have been reported to be associated to HSAN-IIB. We report four patients from two unrelated families who developed during childhood a sensory axonal neuropathy with variable severity and pronounced nociception impairment. Complications such as recurrent ulcerations, osteomyelitis, and osteonecrosis leading to distal amputation were noticed. Dysautonomia was mild or even absent in our group of patients. Additionally, either clinical or neurophysiological motor impairment was not uncommon. Presence of upper motor neuron signs was also a distinctive feature in two related patients. After extensive workup, two novel homozygous mutations in the FAM134B gene were identified. This report expands the clinical and genetic spectrum of HSAN type II and emphasizes the phenotype variability even within the same family.

© 2019 Peripheral Nerve Society.

Keywords

#FAM134B gene; #RETREG1 gene; #hereditary sensory autonomic #neuropathy; #ulcero-mutilating neuropathy

Contact :
Prof. Annick Toutain :